| Insideraktier | 3.299.240 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Kinnate Biopharma Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i KNTE / Kinnate Biopharma Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i KNTE / Kinnate Biopharma Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-05 | 2024-04-03 | 4 | Flaherty Keith T. | KNTE | Common Stock | D | -66.377 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Krishnamohan Neha | KNTE | Common Stock | D | -64.087 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Farzan Nima | KNTE | Common Stock | D | -2.186 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Tananbaum James B. By Fund | KNTE | Common Stock | I | -520.711 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Tananbaum James B. By Fund | KNTE | Common Stock | I | -3.525.957 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Tananbaum James B. By Fund | KNTE | Common Stock | I | -9.671.643 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Meltz Mark A | KNTE | Common Stock | D | -27.578 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | -450.000 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | -84.599 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | -1.368.338 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | -4.738.453 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | -1.368.339 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | -450.000 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | -84.599 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | -1.368.338 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | -4.738.453 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | -1.368.339 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | -520.711 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | -3.525.957 | 0 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | -9.671.643 | 0 | ||||||
| 2024-03-05 | 2024-03-01 | 4 | Krishnamohan Neha | KNTE | Common Stock | D | 2,5900 | -1.506 | -4 | 64.087 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 2,5900 | -558 | -1 | 67.588 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Meltz Mark A | KNTE | Common Stock | D | 2,5900 | -558 | -1 | 27.578 | ||||
| 2023-12-05 | 2023-12-01 | 4 | Krishnamohan Neha | KNTE | Common Stock | D | 2,2500 | -1.459 | -3 | 65.593 | ||||
| 2023-12-05 | 2023-12-01 | 4 | Meltz Mark A | KNTE | Common Stock | D | 2,2500 | -541 | -1 | 28.136 | ||||
| 2023-12-05 | 2023-12-01 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 2,2500 | -541 | -1 | 68.146 | ||||
| 2023-09-06 | 2023-09-01 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 2,3500 | -541 | -1 | 68.687 | ||||
| 2023-09-06 | 2023-09-01 | 4 | Meltz Mark A | KNTE | Common Stock | D | 2,3500 | -541 | -1 | 28.677 | ||||
| 2023-09-06 | 2023-09-01 | 4 | Krishnamohan Neha | KNTE | Common Stock | D | 2,3500 | -1.459 | -3 | 67.052 | ||||
| 2023-06-05 | 2023-06-01 | 4 | Krishnamohan Neha | KNTE | Common Stock | D | 4,3000 | -1.459 | -6 | 68.511 | ||||
| 2023-06-05 | 2023-06-01 | 4 | Meltz Mark A | KNTE | Common Stock | D | 4,3000 | -541 | -2 | 29.218 | ||||
| 2023-06-05 | 2023-06-01 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 4,3000 | -541 | -2 | 69.228 | ||||
| 2023-05-10 | 2023-05-08 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 2,8000 | 229.044 | 641 | 520.711 | ||||
| 2023-05-10 | 2023-05-08 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 2,8000 | 1.550.956 | 4.343 | 3.525.957 | ||||
| 2023-05-10 | 2023-05-08 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 2,8000 | 229.044 | 641 | 520.711 | ||||
| 2023-05-10 | 2023-05-08 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 2,8000 | 1.550.956 | 4.343 | 3.525.957 | ||||
| 2023-05-08 | 2023-05-05 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,8200 | 490.511 | 1.383 | 1.368.338 | ||||
| 2023-05-08 | 2023-05-05 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,8200 | 490.512 | 1.383 | 1.368.339 | ||||
| 2023-05-08 | 2023-05-04 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,7500 | 83.459 | 230 | 877.827 | ||||
| 2023-05-08 | 2023-05-04 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,7500 | 83.459 | 230 | 877.827 | ||||
| 2023-05-08 | 2023-05-04 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,7500 | 312.991 | 861 | 4.738.453 | ||||
| 2023-05-08 | 2023-05-05 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,8200 | 490.511 | 1.383 | 1.368.338 | ||||
| 2023-05-08 | 2023-05-05 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,8200 | 490.512 | 1.383 | 1.368.339 | ||||
| 2023-05-08 | 2023-05-04 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,7500 | 83.459 | 230 | 877.827 | ||||
| 2023-05-08 | 2023-05-04 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,7500 | 83.459 | 230 | 877.827 | ||||
| 2023-05-08 | 2023-05-04 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,7500 | 312.991 | 861 | 4.738.453 | ||||
| 2023-05-02 | 2023-05-02 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,6700 | 58.826 | 157 | 794.368 | ||||
| 2023-05-02 | 2023-05-02 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,6700 | 58.826 | 157 | 794.368 | ||||
| 2023-05-02 | 2023-05-02 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,6700 | 220.610 | 589 | 4.425.462 | ||||
| 2023-05-02 | 2023-05-01 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,6200 | 124.545 | 326 | 735.542 | ||||
| 2023-05-02 | 2023-05-01 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,6200 | 467.068 | 1.224 | 4.204.852 | ||||
| 2023-05-02 | 2023-05-01 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,6200 | 124.544 | 326 | 735.542 | ||||
| 2023-05-02 | 2023-04-28 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,5500 | 60.997 | 156 | 610.997 | ||||
| 2023-05-02 | 2023-04-28 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,5500 | 228.754 | 583 | 3.737.784 | ||||
| 2023-05-02 | 2023-04-28 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2,5500 | 60.998 | 156 | 610.998 | ||||
| 2023-05-02 | 2023-05-02 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,6700 | 58.826 | 157 | 794.368 | ||||
| 2023-05-02 | 2023-05-02 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,6700 | 58.826 | 157 | 794.368 | ||||
| 2023-05-02 | 2023-05-02 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,6700 | 220.610 | 589 | 4.425.462 | ||||
| 2023-05-02 | 2023-05-01 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,6200 | 124.545 | 326 | 735.542 | ||||
| 2023-05-02 | 2023-05-01 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,6200 | 467.068 | 1.224 | 4.204.852 | ||||
| 2023-05-02 | 2023-05-01 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,6200 | 124.544 | 326 | 735.542 | ||||
| 2023-05-02 | 2023-04-28 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,5500 | 60.997 | 156 | 610.997 | ||||
| 2023-05-02 | 2023-04-28 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,5500 | 228.754 | 583 | 3.737.784 | ||||
| 2023-05-02 | 2023-04-28 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2,5500 | 60.998 | 156 | 610.998 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 5,2100 | -638 | -3 | 67.295 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Krishnamohan Neha | KNTE | Common Stock | D | 5,2100 | -1.721 | -9 | 67.378 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Meltz Mark A | KNTE | Common Stock | D | 5,2100 | -638 | -3 | 27.286 | ||||
| 2023-02-23 | 3 | OrbiMed Advisors IV Ltd See footnotes | KNTE | Common Stock | I | 550.000 | ||||||||
| 2023-02-23 | 3 | OrbiMed Advisors IV Ltd See footnotes | KNTE | Common Stock | I | 550.000 | ||||||||
| 2023-02-23 | 2023-02-17 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 550.000 | 550.000 | ||||||
| 2023-02-23 | 2023-02-17 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 550.000 | 550.000 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 1.100.000 | 1.975.001 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 1.100.000 | 1.975.001 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 550.000 | 550.000 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 550.000 | 550.000 | ||||||
| 2022-12-02 | 2022-12-01 | 4 | Krishnamohan Neha | KNTE | Common Stock | D | 7,7500 | -1.459 | -11 | 69.099 | ||||
| 2022-12-02 | 2022-12-01 | 4 | Meltz Mark A | KNTE | Common Stock | D | 7,7500 | -541 | -4 | 27.924 | ||||
| 2022-12-02 | 2022-12-01 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 7,7500 | -541 | -4 | 67.933 | ||||
| 2022-09-02 | 2022-09-01 | 4 | Meltz Mark A | KNTE | Common Stock | D | 25.000 | 28.465 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Krishnamohan Neha | KNTE | Common Stock | D | 67.500 | 69.015 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 25.000 | 68.474 | ||||||
| 2022-03-15 | 2022-03-14 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 8,3700 | 25.000 | 209 | 42.333 | ||||
| 2022-03-15 | 2022-03-11 | 4 | Williams Richard Thomas | KNTE | Common Stock | D | 8,6400 | 15.000 | 130 | 17.333 | ||||
| 2022-02-15 | 2022-02-15 | 4 | GORDON CARL L See Footnotes | KNTE | Common Stock | I | 9,9600 | 9.000 | 90 | 3.509.030 | ||||
| 2022-02-15 | 2022-02-14 | 4 | GORDON CARL L See Footnotes | KNTE | Common Stock | I | 9,8900 | 10.000 | 99 | 3.500.030 | ||||
| 2022-02-15 | 2022-02-14 | 4 | GORDON CARL L See Footnotes | KNTE | Common Stock | I | 9,9800 | 20.700 | 207 | 3.490.030 | ||||
| 2022-02-15 | 2022-02-11 | 4 | GORDON CARL L See Footnotes | KNTE | Common Stock | I | 10,2200 | 156.000 | 1.594 | 3.469.330 | ||||
| 2022-02-15 | 2022-02-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | KNTE | Common Stock | I | 9,9600 | 9.000 | 90 | 3.509.030 | ||||
| 2022-02-15 | 2022-02-14 | 4 | ORBIMED ADVISORS LLC See Footnotes | KNTE | Common Stock | I | 9,8900 | 10.000 | 99 | 3.500.030 | ||||
| 2022-02-15 | 2022-02-14 | 4 | ORBIMED ADVISORS LLC See Footnotes | KNTE | Common Stock | I | 9,9800 | 20.700 | 207 | 3.490.030 | ||||
| 2022-02-15 | 2022-02-11 | 4 | ORBIMED ADVISORS LLC See Footnotes | KNTE | Common Stock | I | 10,2200 | 156.000 | 1.594 | 3.469.330 | ||||
| 2022-02-15 | 2022-02-11 | 4 | Williams Richard Thomas | KNTE | Employee Stock Option (right to buy) | D | 10,03 | 135.000 | 135.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Meltz Mark A | KNTE | Employee Stock Option (right to buy) | D | 10,03 | 135.000 | 135.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Farzan Nima | KNTE | Employee Stock Option (right to buy) | D | 10,03 | 400.000 | 400.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Krishnamohan Neha | KNTE | Employee Stock Option (right to buy) | D | 10,03 | 185.000 | 185.000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | Sabzevari Helen | KNTE | Stock Option (right to buy) | D | 24,38 | 40.501 | 40.501 | |||||
| 2021-06-14 | 2021-06-11 | 4 | MITCHELL DEAN J | KNTE | Stock Option (right to buy) | D | 24,46 | 20.250 | 20.250 | |||||
| 2021-06-14 | 2021-06-11 | 4 | Smaldone Alsup Laurie | KNTE | Stock Option (right to buy) | D | 24,46 | 20.250 | 20.250 | |||||
| 2021-06-14 | 2021-06-11 | 4 | Flaherty Keith T. | KNTE | Stock Option (right to buy) | D | 24,46 | 20.250 | 20.250 | |||||
| 2021-06-14 | 2021-06-11 | 4 | Epperly Melissa B, | KNTE | Stock Option (right to buy) | D | 24,46 | 20.250 | 20.250 | |||||
| 2021-06-08 | 2021-06-07 | 4 | Krishnamohan Neha | KNTE | Employee Stock Option (right to buy) | D | 23,26 | 270.000 | 270.000 | |||||
| 2021-02-16 | 2021-02-12 | 4 | Williams Richard Thomas | KNTE | Employee Stock Option (right to buy) | D | 35,38 | 100.000 | 100.000 | |||||
| 2021-02-16 | 2021-02-12 | 4 | Murphy Eric Anthony | KNTE | Employee Stock Option (right to buy) | D | 35,38 | 60.000 | 60.000 | |||||
| 2021-02-16 | 2021-02-12 | 4 | Meltz Mark A | KNTE | Employee Stock Option (right to buy) | D | 35,38 | 100.000 | 100.000 | |||||
| 2021-02-16 | 2021-02-12 | 4 | Farzan Nima | KNTE | Employee stock option (right to buy) | D | 35,38 | 275.000 | 275.000 | |||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Series C Preferred Stock | I | -24.555 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Series B Preferred Stock | I | -9.461 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Series A Preferred Stock | I | -50.501 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Series C Preferred Stock | I | -118.398 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Series B Preferred Stock | I | -2.651.042 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Series A Preferred Stock | I | -243.494 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 24.637 | 84.599 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 9.461 | 59.962 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 50.501 | 50.501 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 118.794 | 3.313.330 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 2.651.042 | 3.194.536 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 243.494 | 543.494 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Series C Preferred Stock | I | -24.555 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Series B Preferred Stock | I | -9.461 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Series A Preferred Stock | I | -50.501 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Series C Preferred Stock | I | -118.398 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Series B Preferred Stock | I | -2.651.042 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Series A Preferred Stock | I | -243.494 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 24.637 | 84.599 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 9.461 | 59.962 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 50.501 | 50.501 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 118.794 | 3.313.330 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 2.651.042 | 3.194.536 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | GORDON CARL L See footnotes | KNTE | Common Stock | I | 243.494 | 543.494 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series C Preferred Stock | I | -48.376 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series C Preferred Stock | I | -145.128 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series C Preferred Stock | I | -157.222 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series B Preferred Stock | I | -18.641 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series B Preferred Stock | I | -55.922 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series B Preferred Stock | I | -2.666.002 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series A Preferred Stock | I | -99.488 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series A Preferred Stock | I | -298.465 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Series A Preferred Stock | I | -6.347.893 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 166.667 | 291.667 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 500.001 | 875.001 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 9.171.643 | 9.671.643 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series C Preferred Stock | I | -48.376 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series C Preferred Stock | I | -145.128 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series C Preferred Stock | I | -157.222 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series B Preferred Stock | I | -18.641 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series B Preferred Stock | I | -55.922 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series B Preferred Stock | I | -2.666.002 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series A Preferred Stock | I | -99.488 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series A Preferred Stock | I | -298.465 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Series A Preferred Stock | I | -6.347.893 | 0 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 166.667 | 291.667 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 500.001 | 875.001 | ||||||
| 2020-12-09 | 2020-12-07 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 9.171.643 | 9.671.643 | ||||||
| 2020-12-04 | 2020-12-03 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 20,0000 | 125.000 | 2.500 | 125.000 | ||||
| 2020-12-04 | 2020-12-03 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 20,0000 | 375.000 | 7.500 | 375.000 | ||||
| 2020-12-04 | 2020-12-03 | 4 | Tananbaum James B. | KNTE | Common Stock | I | 20,0000 | 500.000 | 10.000 | 500.000 | ||||
| 2020-12-04 | 2020-12-03 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 20,0000 | 125.000 | 2.500 | 125.000 | ||||
| 2020-12-04 | 2020-12-03 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 20,0000 | 375.000 | 7.500 | 375.000 | ||||
| 2020-12-04 | 2020-12-03 | 4 | Foresite Capital Management IV, LLC | KNTE | Common Stock | I | 20,0000 | 500.000 | 10.000 | 500.000 | ||||
| 2020-12-04 | 2020-12-02 | 4 | Tananbaum James B. | KNTE | Stock Option (right to buy) | D | 20,00 | 40.501 | 40.501 | |||||
| 2020-12-04 | 2020-12-02 | 4 | Rome Michael E | KNTE | Stock Option (right to buy) | D | 20,00 | 40.501 | 40.501 | |||||
| 2020-12-04 | 2020-12-02 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 20,0000 | 450.000 | 9.000 | 450.000 | ||||
| 2020-12-04 | 2020-12-02 | 4 | ORBIMED ADVISORS LLC See footnotes | KNTE | Common Stock | I | 20,0000 | 300.000 | 6.000 | 300.000 | ||||
| 2020-12-04 | 2020-12-02 | 4 | GORDON CARL L | KNTE | Common Stock | I | 20,0000 | 450.000 | 9.000 | 450.000 | ||||
| 2020-12-04 | 2020-12-02 | 4 | GORDON CARL L | KNTE | Common Stock | I | 20,0000 | 300.000 | 6.000 | 300.000 | ||||
| 2020-12-04 | 2020-12-02 | 4 | GORDON CARL L | KNTE | Stock Option (right to buy) | D | 20,00 | 40.501 | 40.501 | |||||
| 2020-12-02 | 3 | Flaherty Keith T. | KNTE | Common Stock | D | 66.377 | ||||||||
| 2020-12-02 | 3 | Murphy Eric Anthony | KNTE | Common Stock | D | 1.615.826 | ||||||||
| 2020-12-02 | 3 | Kaldor Stephen W | KNTE | Common Stock | D | 1.615.826 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
